maintenance therapy

Type: Keyphrase
Name: maintenance therapy
First reported Sep 29 2014 - Updated 19 hours ago - 1 reports

Verona Pharma : Shares Up As Data Shows Potential Of RPL554 In Cystic Fibrosis

LONDON ( Alliance News ) - Shares in Verona Pharma PLC were trading up 19% Monday morning after it announced that new data supports the use of its lead molecule, RPL554, for the treatment of cystic fibrosis.RPL554 is presently in Phase 2 clinical development ... [Published 4 Traders - Sep 29 2014]
First reported Sep 25 2014 - Updated Sep 25 2014 - 1 reports

Remicade, Humira and Simponi face NICE knock-back

NICE is set to not recommend a trio of drugs for the treatment of the chronic bowel condition ulcerative colitis.In draft guidance the Institute says Merck Sharpe & Dohme's (MSD) Remicade (Infliximab) and Simponi (golimumab), and AbbVie's Humira adalimumab) ... [Published PMLive - Sep 25 2014]
Entities: infliximab, SIMPONI, HUMIRA
First reported Sep 24 2014 - Updated Sep 24 2014 - 2 reports

NICE opens consultation on three drugs for chronic bowel condition

The National Institute for Health and Care Excellence (NICE) says in draft guidance that infliximab, adalimumab and golimumab should not be recommended for routine use in the NHS to treat moderate to severe ulcerative colitis.An estimated 146,000 people ... [Published NICE - Sep 24 2014]
First reported Sep 23 2014 - Updated Sep 23 2014 - 1 reports

Tamibarotene As Maintenance Therapy for Acute Promyelocytic Leukemia: Results From a Randomized Controlled Trial [Hematologic Malignancy]

PurposeThe introduction of all- trans -retinoic acid (ATRA) has significantly improved outcomes for acute promyelocytic leukemia (APL), although a subset of patients still suffer relapse. The purpose of this study was to evaluate the role of maintenance ... [Published Journal of Clinical Oncology - Sep 23 2014]
First reported Sep 17 2014 - Updated Sep 18 2014 - 1 reports

E-Cigarettes and Maintenance Therapy: A Smart Public Health Approach

Martina Paraninfi viaI don't smoke, but I find myself fascinated by and passionate about the debate over e-cigarettes. Why? Because e-cigarettes illustrate how harm reduction approaches to drug policy, particularly maintenance or substitution therapies, ... [Published Huffington Post - Sep 17 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 1 reports

Routine Use of Maintenance Therapy in Follicular Lymphoma: Examine the Rationale for Maintenance Use Before Uniformly Adopting a Strategy

1. Turner JJ, Morton LM, Linet MS, et al. InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. Blood. 2010;116:e90-8.2. Swenson WT, Wooldridge JE, ... [Published Cancernetwork.com - Sep 15 2014]
First reported Sep 10 2014 - Updated Sep 10 2014 - 2 reports

Findings on Cancer Gene Therapy Reported by Investigators at University College London (Maintenance therapy in ovarian cancer)

By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- Current study results on Biotechnology have been published. According to news originating from London, United Kingdom, by NewsRx ... ... [Published Wall Street Business Network - Sep 10 2014]
First reported Sep 10 2014 - Updated Sep 10 2014 - 2 reports

Optimal Strategy in Early Multiple Myeloma: Melphalan, Transplantation, Maintenance

The optimal treatment strategy for patients with newly diagnosed multiple myeloma is consolidation therapy with high-dose melphalan plus stem-cell transplantation, followed by maintenance therapy with lenalidomide, according to the results of a phase ... [Published Cancernetwork.com - Sep 10 2014]
First reported Sep 07 2014 - Updated Sep 07 2014 - 1 reports

Autologous Transplantation and Maintenance Therapy in Multiple Myeloma

First reported Sep 04 2014 - Updated Sep 04 2014 - 2 reports

New myeloma treatment options show promise

(HealthDay)—New multiple myeloma treatment options appear promising for patients aged 65 years and younger and for newly diagnosed patients who are ineligible for stem-cell transplantation, according to two studies published in the Sept. 4 issue of the ... [Published Medical Xpress - Sep 04 2014]
First reported Sep 04 2014 - Updated Sep 04 2014 - 1 reports

Autologous Transplantation and Maintenance Therapy in Multiple Myeloma

High-dose chemotherapy plus autologous stem-cell transplantation, as compared with conventional chemotherapy, prolongs progression-free survival and overall survival among patients with newly diagnosed multiple myeloma.– and it is currently the standard ... [Published The New England Journal of Medicine: Hematology ... - Sep 04 2014]
First reported Sep 03 2014 - Updated Sep 03 2014 - 1 reports

Treatment Evolution after COPD Diagnosis in the UK Primary Care Setting

by Keele E. Wurst, Yogesh Suresh Punekar, Amit ShuklaRationaleTo assess the treatment progression during the 24 months following a formal diagnosis of chronic obstructive pulmonary disease (COPD) in the UK primary care setting.MethodsA retrospective cohort ... [Published Plosone.org - Sep 03 2014]

Quotes

"We are therefore exploring the potential of the drug in different diseases as well as in the multi-blockbuster markets for COPD and asthma maintenance therapy" said Chief Executive Jan-Anders Karlsson in a statement
The presentation, entitled "CFTR activation by the dual phosphodiesterase 3/4"
"Moderate to severe Crohn's disease is a serious chronic disorder that can impact children and adolescents in significant ways during this important stage of their lives" said Jeffrey S Hyams, MD, head, Division of Digestive Diseases, Hepatology and Nutrition, Connecticut Children's Medical Center, in Hartford
...The patent, titled "Implantable Polymeric Device for Sustained Release of a Dopamine Agonist" provides intellectual property protection of the program for Parkinson's disease and is expected to have an expiration date of at least 2024

More Content

All (110) | News (91) | Reports (0) | Blogs (17) | Audio/Video (0) | Fact Sheets (0) | Press Releases (2)
sort by: Date | Relevance
Improving Survival in Advanced NSCLC: Multiple ... [Published Chemotherapy Advisor - 4 hours ago]
Kamada Announces Second Extension Of Strategic ... [Published TheStreet.com - Sep 29 2014]
Verona Pharma : Shares Up As Data Shows Potenti... [Published 4 Traders - Sep 29 2014]
VERONA PHARMA : New data supports RPL554 as a p... [Published 4 Traders - Sep 29 2014]
ONLINE FIRST: Upfront Transplant in Multiple My... [Published Oncology Times - Sep 27 2014]
Bevacizumab/Capecitabine Combo Shows Promise in... [Published PT Community - Sep 26 2014]
FDA Approves New Indication for Humira: Pediatr... [Published Pharmacy Practice News - Sep 26 2014]
Newnan walk raises awareness for uncommon disease [Published The Times-Herald - Sep 25 2014]
Combination inhaler Anoro Ellipta launched for ... [Published Pharmaceutical Journal - Sep 25 2014]
Remicade, Humira and Simponi face NICE knock-back [Published PMLive - Sep 25 2014]
Weekly Adalimumab Dosing in Ulcerative Colitis [Published General Medicine eJournal - Sep 25 2014]
Strong Enrollment In Phase 3 Trial Means Good N... [Published Seeking Alpha - Sep 24 2014]
NICE opens consultation on three drugs for chro... [Published NICE - Sep 24 2014]
NICE plans 'no' for ulcerative colitis drugs [Published Pharma Times - Sep 24 2014]
TH-302 demonstrates encouraging activity in sof... [Published Orthopedics Today - Sep 23 2014]
Tamibarotene As Maintenance Therapy for Acute P... [Published Journal of Clinical Oncology - Sep 23 2014]
We Wanted More for Our Patients - Orkos Award f... [Published Industrial Info Financials - Sep 19 2014]
New Rapidly Acting Technique Could Be Substanti... [Published Psychiatric News - Sep 19 2014]
As-needed rituximab controlled follicular lymph... [Published Orthopedics Today - Sep 18 2014]
E-Cigarettes and Maintenance Therapy: A Smart P... [Published Huffington Post - Sep 17 2014]
National Osteoporosis Society Vitamin D Guideli... [Published General Medicine eJournal - Sep 17 2014]
Journal of Clinical Psychiatry: Long-term Benef... [Published ScienceNewsline - Sep 17 2014]
"NO ONE SHOULD HAVE TO... [Published Spice4Life - Sep 16 2014]
Folliculitis facts [Published The News International - Sep 16 2014]
NEJM and ERS publish positive results from GSK ... [Published Drugs.com - Sep 16 2014]
Routine Use of Maintenance Therapy in Follicula... [Published Cancernetwork.com - Sep 15 2014]
Beyond the Clinical Trial [Published OncLive - Sep 14 2014]
Bleach-based gel wash improves severity of atop... [Published Dermatology Times - Sep 13 2014]
VERONA PHARMA : Interim results for the six mon... [Published 4 Traders - Sep 12 2014]
Mental health: Primary care lithium monitoring [Published GP Online - Sep 12 2014]
1 2 3 4
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Autologous Transplantation and Maintenance Ther... [Published NEJM Most Viewed Articles - Week - Sep 10 2014]
Autologous Transplantation and Maintenance Ther... [Published NEJM Most Emailed Articles - Sep 07 2014]
Propeller Health raises $14.5M for GPS asthma i... [Published Venturebeat - Sep 04 2014]
Above: Propeller Health's device attaches to the end of an inhaler. Image Credit: Propeller Health Asthma and chronic obstructive pulmonary disease (COPD) currently cost payers and patients in the United States over $100 billion annually. By 2020, ...
Propeller Health fetches $14.5 mln Series B [Published PE Hub Blog - Sep 04 2014]
Propeller Health said Thursday that it has closed $14.5 million in Series B funding. Safeguard Scientifics led the round with participation from return backer The Social+Capital Partnership . Also, the firm has hired Chris Hogg as COO. Propeller ...
Autologous Transplantation and Maintenance Ther... [Published The New England Journal of Medicine: Hematology ... - Sep 04 2014]
High-dose chemotherapy plus autologous stem-cell transplantation, as compared with conventional chemotherapy, prolongs progression-free survival and overall survival among patients with newly diagnosed multiple myeloma.– and it is currently the standard ...
1 2 3 4

Press Releases

sort by: Date | Relevance
Genmab Announces Financial Results for the Firs... [Published GlobeNewswire: Acquisitions News - Aug 13 2014]
Positive Top-line Results from Two Phase 3 Clin... [Published GlobeNewswire: Advertising News - Jun 23 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.